Safety and efficacy outcomes in patients undergoing pulmonary vein isolation with second-generation cryoballoon

Aims The second-generation cryoballoon (Arctic Front Advance (TM)) (Arc-Adv-CB) has a redesigned injection system which distributes the refrigerant homogenously to the frontal balloon surface. The aim of this study was to compare the efficacy and safety of the Arc-Adv-CB and its predecessor (Arctic...

Full description

Bibliographic Details
Published in:Europace
Main Authors: Ates, Ahmet Hakan, EVRANOS, BANU, Dural, Muhammet, KOÇYİĞİT, DUYGU, YALÇIN, MUHAMMED ULVİ, OTO, MEHMET ALİ, Kaya, Ergun Bans, ŞAHİNER, MEHMET LEVENT, YORGUN, HİKMET, GÜRSES, KADRİ MURAT, AYTEMİR, KUDRET
Format: Article in Journal/Newspaper
Language:English
Published: 2015
Subjects:
Arctic
Online Access:https://doi.org/10.1093/europace/euu273
https://avesis.hacettepe.edu.tr/publication/details/00c664f6-856b-48e4-8a05-629ef63c696e/oai
Description
Summary:Aims The second-generation cryoballoon (Arctic Front Advance (TM)) (Arc-Adv-CB) has a redesigned injection system which distributes the refrigerant homogenously to the frontal balloon surface. The aim of this study was to compare the efficacy and safety of the Arc-Adv-CB and its predecessor (Arctic Front (TM)) (Arc-CB) in patients who underwent pulmonary vein isolation (PVI) for atrial fibrillation (AF).

Similar Items